Lexicon Pharmaceuticals, Inc.

( )
LXRX After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Biotechnology
GILDGilead Sciences, Inc. -3.01%72.511.0%$1825.82m
AMGNAmgen, Inc. -2.43%197.811.3%$868.05m
REGNRegeneron Pharmaceuticals, Inc. 1.71%496.652.6%$847.12m
BIIBBiogen, Inc. -7.31%293.271.5%$701.26m
VRTXVertex Pharmaceuticals, Inc. -5.24%225.481.9%$548.05m
MRNAModerna, Inc. -0.94%29.670.0%$496.02m
ILMNIllumina, Inc. -6.10%256.463.5%$445.50m
ALXNAlexion Pharmaceuticals, Inc. 0.16%89.932.0%$283.26m
AAgilent Technologies, Inc. -3.67%68.991.6%$216.32m
EXASEXACT Sciences Corp. -3.66%55.8821.0%$182.49m
INCYIncyte Corp. 1.30%74.182.5%$177.83m
BMRNBioMarin Pharmaceutical, Inc. -1.08%83.594.3%$161.67m
SGENSeattle Genetics, Inc. -3.59%111.246.1%$150.70m
NVAXNovavax, Inc. 3.31%14.03114.7%$123.70m
ALNYAlnylam Pharmaceuticals, Inc. -3.96%104.548.7%$96.98m

Company Profile

Lexicon Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of pharmaceutical products for the treatment of human disease. Its drug candidates include XERMELO, Zynquista, and LX9211. The company was founded by Brian P. Zambrowicz and Arthur T. Sands on July 7, 1995 and is headquartered in The Woodlands, TX.